BioCentury | Jun 17, 2013
Company News

RepliCel, Shiseido deal

...RepliCel granted skincare company Shiseido exclusive rights to RCH-01 hair regeneration technology in Japan, China, South...
...are slated to begin later this year. RepliCel Life Sciences Inc. (OTCBB:REPCF; CNSX:RP), Vancouver, B.C. Shiseido Co. Ltd....
BioCentury | Sep 22, 1997
Company News

BioStratum, Cutaneous Biology Research Center, Fred Hutchinson Cancer Research Center, Shiseido Co. Ltd. deal

...BioStratum and Shiseido will develop skin regeneration formulations based on production of recombinant laminins. The formulations...
...healing and minimize scarring. Laminins are heterotrimeric extracellular matrix proteins that underlie many tissue types. Shiseido...
...Hospital and Harvard Medical School, which will collaborate with the partners to develop the formulation. Shiseido...
Items per page:
1 - 2 of 2
BioCentury | Jun 17, 2013
Company News

RepliCel, Shiseido deal

...RepliCel granted skincare company Shiseido exclusive rights to RCH-01 hair regeneration technology in Japan, China, South...
...are slated to begin later this year. RepliCel Life Sciences Inc. (OTCBB:REPCF; CNSX:RP), Vancouver, B.C. Shiseido Co. Ltd....
BioCentury | Sep 22, 1997
Company News

BioStratum, Cutaneous Biology Research Center, Fred Hutchinson Cancer Research Center, Shiseido Co. Ltd. deal

...BioStratum and Shiseido will develop skin regeneration formulations based on production of recombinant laminins. The formulations...
...healing and minimize scarring. Laminins are heterotrimeric extracellular matrix proteins that underlie many tissue types. Shiseido...
...Hospital and Harvard Medical School, which will collaborate with the partners to develop the formulation. Shiseido...
Items per page:
1 - 2 of 2